Specific inhibition of the Survivin-CRM1 interaction by peptide-modified molecular tweezers

Annika Meiners1, Sandra Bäcker1, Inesa Hadrović2

  • 1Department of Molecular Biology II, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Nature Communications
|March 9, 2021
PubMed

Insights

Researchers developed supramolecular tweezers to block Survivin

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Chemical Biology

Background:

  • Survivin is a key protein regulating apoptosis and cell proliferation.
  • Survivin's interaction with the export receptor CRM1 is crucial for its function and a target for cancer therapy.
  • The nuclear export signal (NES) of Survivin is the binding site for CRM1.

Purpose of the Study:

  • To develop a novel strategy to inhibit Survivin-CRM1 interaction.
  • To target Survivin's nuclear export signal (NES) using advanced molecular tools.

Main Methods:

  • Design and synthesis of supramolecular tweezers with peptidic recognition elements.
  • Biochemical assays to demonstrate sequence-selective NES recognition.
  • Molecular dynamics simulations and multiscale computational studies.

Main Results:

  • The developed supramolecular tweezers specifically recognized Survivin's NES.
  • Interference with the critical Survivin-CRM1 receptor interaction was demonstrated.
  • Computational studies supported the experimental findings.

Conclusions:

  • Supramolecular tweezers offer a novel approach to target protein-protein interactions.
  • This strategy provides a proof-of-principle for specific interference with nuclear export signals.
  • The concept is potentially transferable to other protein epitopes with accessible lysine residues.